{
  "id": 219025,
  "title": "Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Provides Update on Recent Business Progress",
  "url": "https://urgent.news/2026/08/06/aurinia-pharmaceuticals-reports-financial-results-for-the-three-and",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-06T12:10:23.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/aurinia-pharmaceuticals-reports-financial-results-for-the-three-and-six-months-ended-june-30-2026-and-provides-update-on-recent-business-progress"
  },
  "original_language": "en",
  "account": null,
  "summary": "ROCKVILLE, Md. & EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and six months ended June 30, 2026 and provided an update on recent business progress. Financial Results Total Revenue: For the three and six months ended June 30, 2026, total revenue was $83.2 million and $160.9 million, […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}